$6.03
-0.140 (-2.27%)
At Close: Jun 03, 2026
Evolus Reports Third Quarter 2020 Results and Provides Business Update
04:05pm, Thursday, 29'th Oct 2020
Q3 2020 Net Revenue of $17.7 Million; 34 Percent Increase Over Q3 2019
Shareholder Alert: Robbins LLP Reminds Investors that Evolus, Inc. (EOLS) is Being Sued for Misleading Shareholders
02:29pm, Thursday, 29'th Oct 2020
SAN DIEGO & NEWPORT BEACH, Calif.--(BUSINESS WIRE)---- $EOLS #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that Evolus, Inc. (NASDAQ: EOLS) is being sued for alleged violatio
BENSALEM, Pa.--(BUSINESS WIRE)---- $EOLS #CLASSACTION--DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS)
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Evolus, Inc. ("Evolus” or "the Company") (NASDAQ: EOLS) and certai
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS)
11:00am, Tuesday, 27'th Oct 2020
LOS ANGELES--(BUSINESS WIRE)---- $EOLS #CLASSACTION--Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS)
Shareholder Alert: Robbins LLP Announces that Evolus, Inc. (EOLS) is Being Sued for Misleading Shareholders
12:00am, Thursday, 22'nd Oct 2020
Shareholder rights law firm Robbins LLP announces that a purchaser of Evolus, Inc. (NASDAQ: EOLS) has filed a class action complaint against the compa
KDA : Le Groupe KDA Annonce la Nomination de Jean-Pierre Robert comme Chef de L'exploitation | MarketScreener
03:02pm, Wednesday, 21'st Oct 2020Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) Short Interest Up 28.3% in September
04:16am, Sunday, 18'th Oct 2020
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest tot
Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia
12:00am, Wednesday, 14'th Oct 2020
Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia
Financial Contrast: Aesthetic Medical International Holdings Group (NASDAQ:AIH) versus BioTelemetry (NASDAQ:BEAT)
01:44am, Monday, 28'th Sep 2020
Aesthetic Medical International Holdings Group (NASDAQ:AIH) and BioTelemetry (NASDAQ:BEAT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based
Daewoong Pharmaceutical Welcomes ITC Decision to Review Judge’s Initial Determination
12:00am, Tuesday, 22'nd Sep 2020
Daewoong Pharmaceutical Co., Ltd. today commented on the decision by the United States International Trade Commission to comprehensively reconsider a
Stemson Therapeutics Secures $7.5M Seed Financing for the Development of Breakthrough Hair Regeneration Therapy to Cure Hair Loss
12:00am, Wednesday, 16'th Sep 2020
Stemson secured a $7.5 million seed financing led by Allergan Aesthetics and Fortunis Capital to develop Stemson’s solution to cure hair loss.
Wilmington waterfront gets a big boost as $52 million construction project is awarded
11:51pm, Thursday, 20'th Aug 2020
The project, which includes a community park adjacent to Banning’s Landing and will take 2 1/2 years to construct, is expected break ground in the fall.
Evolus Inc (EOLS) Q2 2020 Earnings Call Transcript
05:00am, Tuesday, 11'th Aug 2020
With me on today's call are David Moatazedi, president and chief executive officer; Lauren Silvernail, chief financial officer and EVP, corporate development; Mike Jafar, chief marketing officer; Rui
Evolus Reports Second Quarter 2020 Results and Provides Business Update
08:05pm, Monday, 10'th Aug 2020
Q2 2020 Net Revenue $7.8 Million, Up from $2.3 Million in Q2 2019 $40 Million Convertible Note Financing Closed in July 2020 Pro Forma June 30, 2020 Cash1 Position of $124.8 MillionNEWPORT BEACH,
Sign In
Buy EOLS